Humana (HUM) Tops Q3 EPS by 13c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise by about $1/bbl on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
Humana (HUM) PT Lowered to $290 at BMO Capital on 3Q Report; 'Increased Competition in Medicare'
November 10, 2017 10:04 AM ESTBMO Capital lowered its price target on Humana (NYSE: HUM) to $290.00 (from $300.00) while maintaining a Outperform rating, following the company's third quarter earnings report.
Analyst Matt Borsch notes a reduced price target on the shares due to a lower than expected initial outlook... More
